Compare BLFY & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLFY | TMCI |
|---|---|---|
| Founded | 1939 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.3M | 174.6M |
| IPO Year | N/A | 2021 |
| Metric | BLFY | TMCI |
|---|---|---|
| Price | $12.62 | $2.86 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $10.00 | $4.96 |
| AVG Volume (30 Days) | 272.4K | ★ 970.4K |
| Earning Date | 01-28-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $44,731,000.00 | ★ $218,879,000.00 |
| Revenue This Year | $19.85 | $3.25 |
| Revenue Next Year | $20.18 | $0.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.52 | 7.90 |
| 52 Week Low | $7.61 | $2.36 |
| 52 Week High | $13.13 | $10.79 |
| Indicator | BLFY | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 62.91 | 50.24 |
| Support Level | $12.25 | $2.42 |
| Resistance Level | $12.93 | $2.56 |
| Average True Range (ATR) | 0.28 | 0.17 |
| MACD | -0.14 | 0.12 |
| Stochastic Oscillator | 39.77 | 82.50 |
Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.